| Released | Contributor | Author | Title | Pages | Price |
| 29-Dec-2009 | Wright Reports |
N/A
| Wright Investors Service Comprehensive Report for Cornerstone Therapeutics Incorporation | 50 |
$65 |
| 28-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for BIOTECHNOLOGY | 18 |
$49 |
| 28-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for CRTX | 13 |
$25 |
| 25-Dec-2009 | Pechala's Reports | Frantisek Pechala | CRITICAL THERAPEUTICS INC (CRTX=US) 12-months forecast | 1 |
$15 |
| 24-Dec-2009 | Pechala's Reports | Lubomir Pechala | CRITICAL THERAPEUTICS INC (CRTX=US) 2-weeks forecast | 1 |
$10 |
| 23-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: CORNERSTONE THER -- CRTX | 1 |
$4 |
| 23-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ALNY , AGEN , CRTX , DVAX , PTN , SGEN , SNMX -- DRUGS | 3 |
$4 |
| 23-Dec-2009 | Jefferson Research |
N/A
| Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of CORNERSTONE THERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 3 |
$20 |
| 16-Nov-2009 | Wall Street Transcript ,The | The Wall St Transcript | MANAGEMENT TURNOVER REPORT - Critical Therapeutics, Inc. (CRTX) | 5 |
$50 |
0.15% Nasdaq 
0.06%
Research Reports
